DBV TECHNOLOGIES
DEAD

Serial Number

79155972

Owner

DBV TECHNOLOGIES

Filing Date

Jul 18, 2014

Add to watchlist:

No watchlists yet
View on USPTO

DBV TECHNOLOGIES Trademark

Serial Number: 79155972 • Registration: 4834100

DBV TECHNOLOGIES is a trademark filed by DBV TECHNOLOGIES on July 18, 2014. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

DBV TECHNOLOGIES (42 trademarks)

177-181 avenue Pierre Brossolette
Montrouge 92120 , FR

Entity Type: 99

DBV TECHNOLOGIES (Société Anonyme) (2 trademarks)

177-181 avenue Pierre Brossolette

Entity Type: 99

Trademark Details

Filing Date

July 18, 2014

Registration Date

October 20, 2015

Published for Opposition

August 4, 2015

Cancellation Date

July 19, 2024

Goods & Services

Medicated adhesive devices in the nature of epicutaneous patches for enabling cutaneous or epicutaneous administration of medicated or pharmaceutical substances in powder form for humans and animals for the treatment of allergies, inflammatory and autoimmune diseases; epicutaneous patches featuring a preparation in powder form for medical purposes for the treatment of allergies, inflammatory and autoimmune diseases; medicated occlusion patches in the nature of epicutaneous patches for enabling the absorption of a medicated substance in powder form via the skin for the treatment of allergies, inflammatory and autoimmune diseases

Medical services that use a desensitization method that uses immunotherapy; medical treatments of allergies, inflammatory and autoimmune diseases via administration of allergens, antigens using a patch to be affixed to the unbroken skin of the patient, thus avoiding the allergen being transferred into the blood; medical treatments of allergies, inflammatory and autoimmune diseases that use the epicutaneous method of desensitization via immunotherapy; epicutaneous medical treatments of allergies, inflammatory and autoimmune diseases without prior preparation of the skin other than for simple, light cleansing to keep the cellular structure of the epidermis intact; medical consultancy in the field of desensitization to allergies relating to desensitization to combat allergies

Medical apparatus, instruments and devices, namely, epicutaneous patches sold without medication for the cutaneous or epicutaneous administration of substances of medicated or cosmetic substances in powder form for humans or animals; occlusion patch dispensers for medical purposes; medical instruments using the electrostatic properties of a biocompatible support, namely, epicutaneous patches sold without medication

Medical and scientific research in the field of immunotherapy, namely, designing scientific methods for epicutaneous immunotherapy, inflammatory and autoimmune diseases without prior preparation of the skin other than simple and light cleaning in order to leave the cell structure of the skin intact; scientific research in the field of treating and caring for allergies; scientific research in the field of allergy treatment for a treatment to be applied repeatedly to the skin of the patient without prior preparation of the skin other than simple and light cleaning in order to leave the cell structure of the skin intact and thus avoiding the passage of the allergen into the blood; drug discovery services for the discovery of allergen drugs; medical and scientific research, namely, designing methods for treating allergies via the combination of allergens with immune cells in the skin; medical and scientific research, namely, designing methods for treating allergies, inflammatory and autoimmune diseases via the application of a patch to the unbroken skin of the patient without prior preparation of the skin other than simple and light cleaning in order to leave the cell structure of the skin intact

Filing History

DEATH OF INTERNATIONAL REGISTRATION
Feb 8, 2025 DETH
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jul 13, 2024 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Jun 15, 2024 NREP
TOTAL INVALIDATION PROCESSED BY THE IB
Mar 20, 2023 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Feb 24, 2023 INTS
INVALIDATION PROCESSED
Feb 24, 2023 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Jan 6, 2023 INTR
CANCELLED SECTION 71
May 6, 2022 C71T
NEW REPRESENTATIVE AT IB RECEIVED
Nov 1, 2021 NREP
CHANGE OF NAME/ADDRESS REC'D FROM IB
May 4, 2017 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 15, 2016 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Feb 29, 2016 XXSS
GENERIC MADRID TRANSACTION CREATED
Feb 29, 2016 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 20, 2016 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 20, 2015 R.PR
POST PUBLICATION AMENDMENT - ENTERED
Sep 16, 2015 CHPB
ASSIGNED TO PETITION STAFF
Sep 16, 2015 APET
TEAS POST PUBLICATION AMENDMENT RECEIVED
Sep 10, 2015 EPPA
PUBLISHED FOR OPPOSITION
Aug 4, 2015 PUBO
NOTICE OF PUBLICATION
Jul 15, 2015 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 27, 2015 PREV
ASSIGNED TO LIE
Jun 27, 2015 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 10, 2015 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 1, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 1, 2015 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jun 1, 2015 ERFR
ASSIGNED TO EXAMINER
May 21, 2015 DOCK
CONTINUATION OF FINAL REFUSAL MAILED
Apr 29, 2015 CNCF
ACTION CONTINUING A FINAL - COMPLETED
Apr 29, 2015 CNCF
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 14, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 13, 2015 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 13, 2015 ERFR
FINAL REFUSAL MAILED
Feb 23, 2015 CNFR
FINAL REFUSAL WRITTEN
Feb 22, 2015 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 26, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 26, 2015 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 26, 2015 TROA
REFUSAL PROCESSED BY IB
Jan 4, 2015 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 16, 2014 RFCS
REFUSAL PROCESSED BY MPU
Dec 16, 2014 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 13, 2014 RFCR
NON-FINAL ACTION WRITTEN
Dec 12, 2014 CNRT
APPLICATION FILING RECEIPT MAILED
Dec 12, 2014 MAFR
ASSIGNED TO EXAMINER
Dec 8, 2014 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 8, 2014 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 4, 2014 REPR